Related Experiment Video

Updated: Jun 18, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease

Ana I Rojo1, Nadia G Innamorato, Ana M Martín-Moreno

  • 1Centro de Investigación en Red sobre Enfermedades Neurodegenerativas, Spain.

Glia
|November 13, 2009
PubMed

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency exacerbates neuroinflammation and dopaminergic dysfunction in Parkinson's disease models. Nrf2 is crucial for balancing microglial activation, making it a potential therapeutic target for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Neural injury triggers microglial activation, potentially driving neurodegeneration through chronic inflammation.
  • Reactive oxygen species (ROS) may mediate the shift from beneficial to detrimental microglial activity.
  • The role of Nuclear factor erythroid 2-related factor 2 (Nrf2) in modulating microglial responses to oxidative stress is not fully understood.

Purpose of the Study:

  • To investigate the role of Nrf2 in regulating microglial activation and neuroinflammation in a Parkinson's disease model.
  • To determine if Nrf2 deficiency exacerbates MPTP-induced dopaminergic neurodegeneration.
  • To elucidate the mechanisms by which Nrf2 influences the balance between classical and alternative microglial activation.

Main Methods:

  • Utilized Nrf2-knockout mice, which are hypersensitive to oxidative stress.
  • Administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) daily for 4 weeks to induce Parkinsonian pathology.
  • Assessed dopaminergic dysfunction, microgliosis, astrogliosis, and inflammatory marker expression (mRNA and protein levels).
  • Confirmed findings using in vitro microglial cultures stimulated with apoptotic conditioned medium.

Main Results:

  • Nrf2-knockout mice showed more severe dopaminergic dysfunction and increased astrogliosis and microgliosis compared to wild-type littermates after MPTP treatment.
  • MPTP treatment increased classical microglial activation markers (COX-2, iNOS, IL-6, TNF-alpha) and decreased alternative activation markers (FIZZ-1, YM-1, Arginase-1, IL-4) in Nrf2-deficient mice.
  • Peripheral macrophage infiltration did not significantly increase, suggesting Nrf2 primarily impacts resident microglia.
  • In vitro studies confirmed Nrf2's role in balancing microglial activation states.

Conclusions:

  • Nrf2 plays a critical role in modulating microglial dynamics and preventing detrimental neuroinflammation.
  • Nrf2 deficiency shifts microglia towards a pro-inflammatory classical activation phenotype, worsening neurodegeneration.
  • Targeting Nrf2 represents a promising therapeutic strategy to control microglial function and mitigate Parkinson's disease progression.

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...